Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 29Ovarian Neoplasms 27Breast Neoplasms 27Lung Neoplasms 26Carcinoma, Ovarian Epithelial 20Fallopian Tube Neoplasms 15Adenocarcinoma of Lung 14Head and Neck Neoplasms 13Brenner Tumor 11Uterine Cervical Neoplasms 10Squamous Cell Carcinoma of Head and Neck 10Urinary Bladder Neoplasms 9Esophageal Neoplasms 9Stomach Neoplasms 8Endometrial Neoplasms 8Urethral Neoplasms 7Adenocarcinoma, Bronchiolo-Alveolar 6Sarcoma 5Prostatic Neoplasms 5Adenocarcinoma Of Esophagus 5Neurotoxicity Syndromes 4Neoplasm Metastasis 4Testicular Neoplasms 3Salivary Gland Neoplasms 3Radiation Injuries 3Esophageal Squamous Cell Carcinoma 3Breast Neoplasms, Male 3Thymoma 2Testicular Germ Cell Tumor 2Small Cell Lung Carcinoma 2

Interventions

pegfilgrastim 1Taxes 1Paclitaxel 1Chemotherapy, Adjuvant 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Communicable Diseases × Paclitaxel × Clear all
NCT00352300 2014-12-31

Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer

GOG Foundation

Phase 1 Completed
43 enrolled
Gynecologic

Communicable Diseases, Fallopian Tube Neoplasms, Neutropenia, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡